View the OMNAPIL-100 registration information details.
Back to drug list
ItemsDrug Registration information
ID2430
No2430
Brand NameOMNAPIL-100
IngredientsCEFIXIME (AS TRIHYDRATE) IP EQ.TO CEFIXIME ANHYDROUS 100 MG/5ML
Dosage FormPOWDER FOR ORAL SUSPENSION
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30 ML/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF THE FOLLOWING INFECTIONS WHEN CAUSED BY SUSCEPTIBLE ORGANISMS: ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, COMMUNITY-ACQUIRED PNEUMONIA, LOWER URINARY TRACT INFECTION, PYELONEPHRITIS, OTITIS MEDIA, SINUSITIS, PHARYNGITIS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO OFF WHITE GRANULAR POWDER FILLED IN CLEAR USP TYPE III, GLASS BOTTLE HAVING YELLOW COLOR SUSPENSION AFTER RECONSTITUTION
Note
License OwnerTHC SOLE CO.,LTD
ManufacturerPSYCHOTROPICS INDIA LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4928/20
FDD Registration Date11/12/2023
Expiry Date10/12/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA